XTENT, Inc. - Corporate Information

Corporate Information

The investor pages that follow are your resource for financial information about XTENT, Inc.. In this section you will find information about our current and historical share price, SEC filings, an electronic version of our annual report and frequently asked questions as well as forms to request additional information.

Recent Releases

Jun 4, 2009
XTENT, Inc. Receives Conditional Approval for Investigational Device Exemption of Custom NX(R) Drug Eluting Stent System from United States Food and Drug Administration

May 15, 2009
XTENT, Inc. Announces Approval of Plan of Liquidation and Dissolution by Board of Directors and Filing of Proxy Materials With the SEC

Events

May 13, 2008
XTENT CUSTOM III Results Webcast and Slide Presentation

Mar 18, 2008
Cowen and Company's 28th Annual Health Care Conference